Target intelligence / Profile preview

Other replicative DNA polymerases

Molecular classification
Enzyme, DNA-directed DNA polymerase, Transferase
01

Overview

Other replicative DNA polymerases is a collective classification, primarily used in pharmacological databases like ChEMBL, to refer to the processive eukaryotic DNA polymerases, specifically DNA polymerase delta (Pol δ) and DNA polymerase epsilon (Pol ε). These enzymes are distinct from DNA polymerase alpha-primase, as they are responsible for the bulk of genomic DNA synthesis on the lagging and leading strands, respectively. They are characterized by high processivity, facilitated by their interaction with the Proliferating Cell Nuclear Antigen (PCNA) sliding clamp, and high fidelity due to their intrinsic 3'-5' exonuclease proofreading activity. Mutations in the catalytic subunits of these polymerases (POLE and POLD1) are linked to hypermutated and ultramutated cancer phenotypes, particularly in colorectal and endometrial cancers, making them significant biomarkers for predicting response to immune checkpoint inhibitors. Pharmacologically, these polymerases are targeted by various nucleoside analogs and antimetabolites that act as competitive inhibitors or chain terminators to disrupt DNA replication and induce apoptosis in rapidly dividing cells.

Other names
DNA polymerase deltaDNA polymerase epsilonProcessive DNA polymerasesB-family DNA polymerasesPOLDPOLE
02

Mechanism of action

Inhibition of DNA synthesis through competitive inhibition with natural deoxynucleoside triphosphates (dNTPs) or by acting as DNA chain terminators upon incorporation into the nascent DNA strand.

03

Biological functions

DNA replicationDNA repairProofreadingGenome maintenanceLong-patch base excision repairNucleotide excision repair
04

Disease associations

CancerLynch syndromeImmunodeficiencyColorectal cancerEndometrial cancer
05

Safety considerations

MyelosuppressionGastrointestinal toxicityNephrotoxicityNeurotoxicity
06

Interacting drugs

Aphidicolin

5 more in the full profile.

07

Biomarkers

POLE mutation statusPOLD1 mutation statusTumor Mutational Burden (TMB)Microsatellite instability (MSI)

Beyond the preview

Go deeper on Other replicative DNA polymerases.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Other replicative DNA polymerases.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call